Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Boston Scientific Corporation (NYSE:BSX). In a filing disclosed on July 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in Boston Scientific stock on June 11th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Sold $15,001 – $50,000 in shares of SpringWorks Therapeutics (NASDAQ:SWTX) on 7/1/2025.
- Purchased $1,001 – $15,000 in shares of AppLovin (NASDAQ:APP) on 7/1/2025.
- Sold $1,001 – $15,000 in shares of Amdocs (NASDAQ:DOX) on 6/30/2025.
- Purchased $1,001 – $15,000 in shares of CoStar Group (NASDAQ:CSGP) on 6/30/2025.
- Purchased $15,001 – $50,000 in shares of CoStar Group (NASDAQ:CSGP) on 6/27/2025.
- Purchased $1,001 – $15,000 in shares of Xiaomi (OTCMKTS:XIACF) on 6/27/2025.
- Sold $1,001 – $15,000 in shares of ASML (NASDAQ:ASML) on 6/27/2025.
- Sold $1,001 – $15,000 in shares of Willis Towers Watson Public (NASDAQ:WTW) on 6/26/2025.
- Sold $1,001 – $15,000 in shares of Boston Scientific (NYSE:BSX) on 6/26/2025.
- Sold $1,001 – $15,000 in shares of Liberty Media Corporation – Liberty Formula One Series C (NASDAQ:FWONK) on 6/26/2025.
Boston Scientific Price Performance
Shares of NYSE:BSX opened at $103.68 on Friday. The business’s 50 day simple moving average is $103.42 and its 200-day simple moving average is $101.08. The firm has a market capitalization of $153.39 billion, a price-to-earnings ratio of 75.68, a price-to-earnings-growth ratio of 2.69 and a beta of 0.68. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.45 and a quick ratio of 0.88. Boston Scientific Corporation has a 12 month low of $71.88 and a 12 month high of $107.53.
Analyst Ratings Changes
Several analysts have recently weighed in on the company. Wall Street Zen upgraded Boston Scientific from a “hold” rating to a “buy” rating in a research note on Tuesday, April 29th. Erste Group Bank raised shares of Boston Scientific to a “strong-buy” rating in a report on Thursday, May 8th. Morgan Stanley raised their target price on shares of Boston Scientific from $120.00 to $125.00 and gave the stock an “overweight” rating in a report on Friday, May 16th. Needham & Company LLC reissued a “buy” rating and issued a $115.00 target price on shares of Boston Scientific in a report on Wednesday, May 28th. Finally, Robert W. Baird raised their target price on shares of Boston Scientific from $115.00 to $120.00 and gave the stock an “outperform” rating in a report on Thursday, April 24th. Twenty-two research analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $116.09.
Get Our Latest Report on Boston Scientific
Insider Buying and Selling
In other news, EVP Arthur C. Butcher sold 17,314 shares of the company’s stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $102.06, for a total transaction of $1,767,066.84. Following the completion of the transaction, the executive vice president owned 22,235 shares of the company’s stock, valued at approximately $2,269,304.10. This represents a 43.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP John Bradley Sorenson sold 4,572 shares of the company’s stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $104.54, for a total transaction of $477,956.88. Following the transaction, the executive vice president directly owned 18,705 shares of the company’s stock, valued at $1,955,420.70. This represents a 19.64% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 461,970 shares of company stock valued at $47,755,193 in the last quarter. Insiders own 0.50% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Brighton Jones LLC boosted its holdings in Boston Scientific by 0.8% in the fourth quarter. Brighton Jones LLC now owns 27,376 shares of the medical equipment provider’s stock worth $2,445,000 after purchasing an additional 226 shares in the last quarter. Bank Pictet & Cie Europe AG boosted its holdings in Boston Scientific by 40.8% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 73,096 shares of the medical equipment provider’s stock worth $6,529,000 after purchasing an additional 21,173 shares in the last quarter. Highview Capital Management LLC DE boosted its holdings in Boston Scientific by 6.2% in the fourth quarter. Highview Capital Management LLC DE now owns 24,507 shares of the medical equipment provider’s stock worth $2,189,000 after purchasing an additional 1,439 shares in the last quarter. Proficio Capital Partners LLC boosted its holdings in Boston Scientific by 40.2% during the fourth quarter. Proficio Capital Partners LLC now owns 5,333 shares of the medical equipment provider’s stock valued at $476,000 after acquiring an additional 1,528 shares during the period. Finally, Independent Advisor Alliance grew its position in shares of Boston Scientific by 136.3% in the fourth quarter. Independent Advisor Alliance now owns 14,213 shares of the medical equipment provider’s stock valued at $1,270,000 after purchasing an additional 8,199 shares during the last quarter. 89.07% of the stock is owned by hedge funds and other institutional investors.
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
Boston Scientific Company Profile
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system.
Read More
- Five stocks we like better than Boston Scientific
- What is a Special Dividend?
- PepsiCo Bottomed Out—Time to Chugalug This Blue-Chip Buy?
- Basic Materials Stocks Investing
- Is J.B. Hunt Stock a Sleeping Giant Heading Into 2026?
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- These 3 Rare Earth Stocks Are Surging Alongside MP Materials
Receive News & Ratings for Boston Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific and related companies with MarketBeat.com's FREE daily email newsletter.